Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ashby

Showing results (41-50 of 435) with videos related to

Pageof 44
Sort By:
Environmental Health Perspectives|January 5, 2002
Confirmation of uterotrophic activity for 4-MBC in the immature ratJ Ashby
Toxicologic Pathology|November 7, 2001
Expectations for transgenic rodent cancer bioassay modelsJ Ashby
Progress in Clinical and Biological Research|January 1, 1986
The value and limitations of short-term genotoxicity assays and the inadequacy of current cancer bioassay chemical selection criteriaJ Ashby
Lancet (London, England)|March 28, 1970
John, 17 monthsJ Ashby
Mutation Research|November 1, 1994
Series: current issues in mutagenesis and carcinogenesis, No. 51. Dose-level selection for in vivo genetic toxicity assaysJ Ashby
Mutation Research|October 1, 1995
Rodent mutation assay data presentation and statistical assessmentJ Ashby
Mutation Research|November 1, 1993
Gambling and the conduct of genetic toxicology testsJ Ashby
Mutation Research|June 1, 1991
Determination of the genotoxic status of a chemicalJ Ashby
Regulatory Toxicology and Pharmacology : RTP|July 2, 1999
Dose levels of 0.01-0.2 microg/kg/day diethylstilbestrol are not suitable for use as a positive control in endocrine toxicity studiesJ Ashby
Mutation Research|September 23, 1996
Naturally occurring organohalogen compoundsJ Ashby
Pageof 44

Showing results (41-50 of 435) with videos related to

Sort By:
Pageof 44
Environmental Health Perspectives|January 5, 2002
Confirmation of uterotrophic activity for 4-MBC in the immature ratJ Ashby
Toxicologic Pathology|November 7, 2001
Expectations for transgenic rodent cancer bioassay modelsJ Ashby
Progress in Clinical and Biological Research|January 1, 1986
The value and limitations of short-term genotoxicity assays and the inadequacy of current cancer bioassay chemical selection criteriaJ Ashby
Lancet (London, England)|March 28, 1970
John, 17 monthsJ Ashby
Mutation Research|November 1, 1994
Series: current issues in mutagenesis and carcinogenesis, No. 51. Dose-level selection for in vivo genetic toxicity assaysJ Ashby
Mutation Research|October 1, 1995
Rodent mutation assay data presentation and statistical assessmentJ Ashby
Mutation Research|November 1, 1993
Gambling and the conduct of genetic toxicology testsJ Ashby
Mutation Research|June 1, 1991
Determination of the genotoxic status of a chemicalJ Ashby
Regulatory Toxicology and Pharmacology : RTP|July 2, 1999
Dose levels of 0.01-0.2 microg/kg/day diethylstilbestrol are not suitable for use as a positive control in endocrine toxicity studiesJ Ashby
Mutation Research|September 23, 1996
Naturally occurring organohalogen compoundsJ Ashby
Pageof 44